Comparison of Early and Delayed Oral Laquinimod in Patients with Relapsing-Remitting Multiple Sclerosis: Effects on Disability Progression at 36 Months in the ALLEGRO Trial

被引：0

作者：

Comi, Giancarlo ^{[1
,2
]}

Jeffery, Douglas

Kappos, Ludwig ^{[3
,4
]}

Montalban, Xavier ^{[5
,6
]}

Boyko, Alexey ^{[7
,8
]}

Rocca, Maria ^{[9
]}

Filippi, Massimo ^{[10
,11
]}

机构：

[1] Univ Vita Salute San Raffaele, Dept Neurol, Milan, Italy

[2] Univ Vita Salute San Raffaele, Inst Expt Neurol, Milan, Italy

[3] Univ Basel, Dept Neurol, Univ Hosp, Basel, Switzerland

[4] Univ Basel, Dept Biomed, Univ Hosp, Basel, Switzerland

[5] Vall dHebron Univ Hosp, Unit Clin Neuroimmunol, Barcelona, Spain

[6] Univ Autonoma Barcelona, E-08193 Barcelona, Spain

[7] Russian State Med Univ, Dept Neurol & Neurosurg, Moscow 117437, Russia

[8] Moscow Multiple Sclerosis Ctr, Moscow, Russia

[9] Univ Vita Salute San Raffaele, Neuroimaging Res Unit, Inst Expt Neurol, Milan, Italy

[10] Univ Vita Salute San Raffaele, Neuroimaging Res Unit, Milan, Italy

[11] Univ Vita Salute San Raffaele, Inst Expt Neurol, Milan, Italy

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

S41004

引用

页数：2